Intellectual Property & Technology partner David Manspeizer (New York) is a panelist on IPO's (the Intellectual Property Owners Association) IP Chat Channel webinar – Blocking Patents in Litigation After Acorda: What's Acorda's Impact Inside and Outside of Pharma? The program, which will take place on February 20, 2020 at 2 pm (EST), will address the application of the blocking patent doctrine, and the multi-factor analysis set forth in Acorda, to obviousness in patent litigation across all technologies.